Mounjaro vs Ozempic: 5 Points You Need to Know
Mounjaro, a dual GIP and GLP-1 receptor agonist, excels in weight loss and blood sugar control, while Ozempic, a GLP-1 agonist, is FDA-approved for A1C lowering with a slightly lower cost. Criteria Mounjaro Ozempic Mechanism of Action GLP-1 and GIP receptor agonist GLP-1 receptor agonist Efficacy Superior for weight loss and blood sugar control FDA-approved … Read more